This paper reviews prior research studies examining neurobiological correla
tes and treatment response of depression in children, adolescents, and adul
ts. Although theta are some similarities in research findings observed acro
ss the life cycle, both children and adolescents have been found to differ
fram depressed adults on measures of basal cortisol sedation, corticotropin
stimulation post-corticotropin releasing hormone (CRH) infusion, response
ra several serotonergic probes immunity indices, and efficacy; of a tricycl
ic medications. These differences are proposed to be doe to 1) developmenta
l factors, 2) stage of illness factors (e.g., number of episodes, total dur
ation of illness), or 3) heterogeneity in clinical outcome (e.g., recurrent
unipolar course vs. new-onset bipolar disorder). Relevant clinical and pre
clinical studies that provide support for these alternate explanations of t
he discrepant findings are reviewed, and directions for future research are
discussed. To determine whether child, adolescent-, and adult-onset depres
sion represent the same condition, it is recommended that researchers II us
e the same neuroimaging paradigms in child, adolescent and adult depressed
cohorts; 2) carefully characterize subjects' stage of illness; and 3) condu
ct longitudinal clinical and repeat neurobiological assessments of patients
of diffrrent ages at various stages of illness. In addition careful attent
ion to familial subtypes (e.g., depressive spectrum disorders vs. familial
pure depressive disorders) and environmental factors; (e.g., trauma history
) are suggested for future investigations, (C) 2001 Society of Biological P
sychiatry.